Bioinformatics Services Market (2026 - 2033)

Bioinformatics Services Market Summary

The global bioinformatics services market size was valued at USD 3.6 billion in 2025 and is projected to grow from USD 4.1 billion in 2026 to USD 11.2 billion by 2033, at a CAGR of 15.4% from 2026 to 2033. North America held the largest share of 45.8% of the global market in 2025. Market growth is being driven by the increasing adoption of next-generation sequencing (NGS), rising investments in genomics and proteomics research, and the growing demand for data analysis solutions in drug discovery and precision medicine. 

The surge in biologics and personalized therapeutics development, along with advancements in artificial intelligence and cloud-based bioinformatics platforms, is further accelerating market expansion.

Market Opportunity Analysis

The growing adoption of precision medicine and personalized healthcare presents significant growth opportunities for the global market. Increasing investments in genomics, proteomics, and multi-omics research, along with the rising use of artificial intelligence and cloud-based analytics platforms, are creating strong demand for advanced bioinformatics solutions.

Moreover, the expansion of drug discovery programs, biomarker identification, and companion diagnostics development is encouraging pharmaceutical and biotechnology companies to outsource bioinformatics services to achieve faster, more efficient data interpretation. Emerging economies are also expected to offer lucrative opportunities driven by improving healthcare infrastructure, rising research funding, and increasing awareness of genomic-based diagnostics and therapeutics.

Market Challenges Analysis

Managing and interpreting massive volumes of complex biological data remains a major challenge for the bioinformatics services industry. The rapid increase in genomic and clinical datasets generated by next-generation sequencing and other omics technologies has created challenges in data storage, integration, standardization, and analysis accuracy. In addition, the shortage of skilled bioinformatics professionals and computational biologists capable of handling advanced analytical workflows further limits market growth. Concerns regarding data privacy, cybersecurity, and regulatory compliance also add complexity to bioinformatics operations, particularly in clinical and healthcare applications involving sensitive patient information.

Market Dynamics

Market Concentration & Characteristics

The bioinformatics services market is witnessing significant innovation driven by advances in artificial intelligence, machine learning, cloud computing, and next-generation sequencing technologies. Companies are increasingly developing automated data analysis platforms, multi-omics integration tools, and AI-based predictive analytics solutions to improve the speed and accuracy of biological data interpretation. Continuous innovation in computational biology and precision medicine applications is further enhancing the efficiency of research and clinical workflows. For instance,in July 2023, FOXO Technologies launched Bioinformatics Services to advance epigenetic data analysis, accelerating innovation in biology, biotechnology, and healthcare while addressing challenges in interpreting epigenetic data.

The bioinformatics service industry is experiencing moderate to high levels of mergers, acquisitions, and strategic collaborations as companies seek to strengthen their technological capabilities and expand their service portfolios. Large biotechnology and pharmaceutical firms are acquiring specialized bioinformatics companies to enhance genomic data analysis, drug discovery, and precision medicine capabilities. Partnerships between research organizations, software providers, and healthcare companies are also increasing to accelerate innovation and market presence. For instance, in April 2025, Illumina and Tempus AI partnered in the U.S. to accelerate precision medicine adoption through genomic AI, multimodal data integration, and enhanced molecular profiling insights across major diseases.

Regulations significantly shape the bioinformatics service market, particularly in data security, patient privacy, and compliance with genomic research standards. Stringent guidelines such as the General Data Protection Regulation (GDPR) in Europe and the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. govern the storage and sharing of genetic data. Regulatory bodies like the FDA and EMA also play a key role in ensuring the accuracy and validity of bioinformatics-driven drug discovery and clinical applications. Compliance with these regulations adds complexity but is essential for market credibility and trust.

Companies in the bioinformatics services industry are continually expanding their offerings to meet the growing demand for genomics, proteomics, transcriptomics, and multi-omics analysis. Service providers are increasingly integrating cloud-based platforms, AI-powered analytics, and customized data interpretation solutions into their portfolios. The expansion of bioinformatics applications in drug discovery, clinical diagnostics, agriculture, and microbial research is further supporting product and service diversification.

Market players are actively expanding their presence in emerging regions such as Asia-Pacific, Latin America, and the Middle East, driven by increased investments in life sciences research and healthcare infrastructure. Growing government funding for genomics projects, rising adoption of precision medicine, and increasing biotechnology activities in countries such as China and India are encouraging companies to strengthen regional operations. Strategic collaborations with local research institutes and healthcare organizations are also supporting geographic expansion efforts.

Case Study: Moderna Using AI and Bioinformatics for Rapid mRNA Vaccine Development

Challenge

Traditional vaccine development requires years of genomic analysis, laboratory testing, and clinical validation. During the COVID-19 pandemic, Moderna needed to rapidly analyze viral genome data and develop an effective vaccine within a very short timeframe.

Solution Implemented

Moderna applied advanced bioinformatics services, artificial intelligence (AI), cloud computing, and machine learning to accelerate mRNA vaccine development. In collaboration with Amazon Web Services and IBM, the company used AI-enabled bioinformatics pipelines to analyze viral genome sequences, optimize mRNA structures, and automate computational modeling workflows before laboratory testing.

Product/Outcome Launched

Moderna successfully launched its mRNA-based COVID-19 vaccine and later expanded the same bioinformatics-driven platform into personalized cancer vaccines, RSV vaccines, influenza vaccines, and other therapeutic programs. The company reportedly completed vaccine sequence selection within only two days using machine-learning-supported infrastructure.

Real-World Impact

This case demonstrated how bioinformatics services can significantly reduce drug and vaccine development timelines, improve genomic data interpretation, and accelerate precision medicine innovation. It also highlighted the growing commercial importance of AI-integrated bioinformatics platforms in pharmaceutical research and healthcare.

Type Insights

The next-generation sequencing (NGS) segment led the market with the largest revenue share of 35.1% in 2025 and is expected to register at the fastest CAGR during the forecast period. The segment growth is primarily driven by the increasing adoption of high-throughput sequencing technologies in genomics, precision medicine, oncology research, and drug discovery. In addition, the rising volume of complex genomic data generated through NGS platforms has significantly increased the demand for advanced bioinformatics services for data analysis, interpretation, and storage.

The scientific software testing segment is expected to register at a significant CAGR during the forecast period. As bioinformatics tools are adopted by a broader range of users, including researchers with varying levels of computational expertise, their usability becomes a critical factor. Software testing aids ensure that bioinformatics applications are functionally robust, intuitive, and accessible to end users. This involves testing for user interface design, workflow integration, and overall user experience. As bioinformatics continues to expand into new fields and user bases, the emphasis on software quality and usability is driving the growth of scientific software testing services.

Application Insights

The drug discovery segment led the market with the largest revenue share of 24.7% in 2025. The increasing complexity of drug development, the rising demand for personalized medicine, and advancements in AI-driven data analysis. Pharmaceutical and biotech companies are leveraging bioinformatics to streamline target identification, lead optimization, and biomarker discovery, reducing time and costs associated with traditional methods. The integration of next-generation sequencing (NGS) and big data analytics enhances predictive modeling, accelerating the identification of potential drug candidates. Moreover, growing collaborations between bioinformatics firms and drug developers, along with regulatory support for data-driven drug discovery, are further fueling market growth.

The proteomics segment is expected to witness at the fastest CAGR over the forecast period. Biomarkers are essential for early disease detection, diagnosis, and personalized treatment strategies. Proteomics plays a crucial role in identifying and validating these biomarkers by analyzing protein expression patterns and modifications. The complexity of proteomics data necessitates the use of advanced bioinformatics tools to identify potential biomarkers and understand their biological significance. As the need for research focused on biomarkers escalates, the demand for bioinformatics services to support this essential component of precision medicine also increases.

Sector Insights

The academic segment led the market with the largest revenue share of 39.6% in 2025 and is expected to grow at the fastest CAGR throughout the forecast period. As bioinformatics has become an integral part of modern biological and medical research, there is a rising demand for educational programs that equip students and researchers with the necessary skills. Universities increasingly offer specialized bioinformatics courses, degrees, and certifications to meet this demand. To support these educational initiatives, academic institutions require access to bioinformatics services that provide the tools and resources needed for teaching and hands-on training. This includes access to databases, software, and computational infrastructure, driving the academic demand for bioinformatics services.

The animal sector is expected to witness at a significant CAGR over the forecast period. Conservation efforts and wildlife genomics are emerging areas where bioinformatics services are becoming increasingly important. Researchers use genomics to study endangered species, understand population genetics, and develop conservation strategies. Bioinformatics plays a key role in analyzing genetic diversity, identifying at-risk populations, and assessing the impact of environmental changes on species. As conservation genomics evolves more data-intensively, the need for bioinformatics services to manage and interpret large-scale genomic data is growing.

Regional Insights

North America dominated the global bioinformatics services market with the largest revenue share of 45.8% in 2025. Companies in the North America region are at the forefront of innovations in genomics, proteomics, and other technologies, driving the demand for bioinformatics services. The region’s well-established infrastructure for biotechnology and life sciences research supports a robust bioinformatics ecosystem, with ongoing investments in advanced research and development. The presence of major players in the industry, coupled with collaborations between academic institutions and private companies, is driving demand for the bioinformatics services in the North America region.

U.S. Bioinformatics Services Market Trends

The bioinformatics services industry in the U.S. accounted for the largest market revenue share in North America in 2025, due to rising investments in genomics research, increasing adoption of sequencing technologies, and strong demand for precision medicine and data-driven drug discovery. For instance, in May 2023, CD Genomics, one of the leading providers of genomics and bioinformatics solutions, introduced its long-read metagenomics sequencing service in the U.S.

Europe Bioinformatics Services Market Trends

The bioinformatics services industry in Europe is propelled by strong governmental funding, increasing collaborations between research institutions and biotech firms, and the rapid adoption of bioinformatics in clinical diagnostics. The rise in genomic studies, particularly in oncology and rare diseases, supports demand. Moreover, the implementation of AI and machine learning in bioinformatics tools enhances efficiency, further driving market growth.

The UK bioinformatics services market is expanding due to growing investments in genomics, AI-driven healthcare innovations, and government-backed initiatives such as Genomics England. The country's focus on precision medicine, supported by leading research institutions, is fueling demand for bioinformatics services. Moreover, increasing public-private partnerships and funding for AI integration in drug discovery boost market growth.

The bioinformatics services market in Germany is expected to grow at a significant CAGR during the forecast period. Germany is a key player in the European market, supported by strong biotechnology research, growing genomic research, and rising investments in precision medicine and digitalization of healthcare.

Asia Pacific Bioinformatics Services Market Trends

The bioinformatics services industry in the Asia Pacific is expected to witness at the fastest CAGR of 16.3% over the forecast period. Research in cancer genomics involves analyzing tumor-specific genetic mutations and identifying biomarkers that guide treatment decisions. Bioinformatics services are essential for managing and interpreting the large datasets generated in cancer genomics studies, including data from next-generation sequencing (NGS) and other high-throughput technologies. The increasing emphasis on personalized oncology and the development of precision cancer treatments are key factors contributing to the regional market expansion.

The China bioinformatics services market is expected to witness at a substantial CAGR over the forecast period, driven by expanding life science research activities, rapid development of healthcare infrastructure, and increasing focus on AI-based genomic analysis and personalized therapeutics.

The bioinformatics services market in Japan is driven by an aging population, which is increasing demand for personalized medicine and genomic research. The country’s focus on regenerative medicine, combined with advancements in AI-driven bioinformatics, supports market growth. Moreover, government initiatives promoting biotech innovation and collaborations between academia and industry fuel further expansion.

Middle East Bioinformatics Services Market Trends

The bioinformatics services industry in the Middle East is expanding due to the rising adoption of data-driven healthcare solutions, growing collaborations in life science research, and increasing demand for advanced disease analysis technologies.

The Kuwait bioinformatics services market is gaining momentum due to increased focus on healthcare modernization, rising adoption of genomic technologies, and growing investments in biomedical and clinical research.

Key Bioinformatics Services Company Insights

The bioinformatics services industry is highly competitive, with key players such as Agilent Technologies, Inc., BGI Group, Dotmatics, Illumina, Inc., QIAGEN, and Thermo Fisher Scientific Inc. focusing on technological advancements, AI-based analytics, cloud platforms, and strategic collaborations to strengthen their bioinformatics service capabilities and global market presence.

Competitive Benchmarking

Recent Developments

• In April 2026, Illumina, Inc., launched DRAGEN v4.5 software to enhance genomic and multiomic analysis capabilities across oncology, rare disease, and germline research workflows using machine learning and pangenome advancements.

"BioInsight is all about making bioinformatics accessible, reliable, and scalable, whether you are a researcher seeking insights into rare disease or a pharma partner pursuing drug discovery from datasets."

-Rami Mehio, senior vice president and general manager of BioInsight at Illumina

• In April 2025, Signios Biosciences in the United States launched an AI-driven bioinformatics and multiomics platform to strengthen precision medicine and drug discovery through integrated genomics, proteomics, transcriptomics, and advanced computational analysis capabilities.

“The challenge today is about how best to pull insights from biological information and organize it in a way that accelerates medical insights.”

-Felix Olale, MD, PhD, CEO and President of Signios Bio.

Bioinformatics Services Market Report Scope

Global Bioinformatics Services Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global bioinformatics services market report based on the type, application, sector, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • NGS

    • Targeted Sequencing Analysis

    • Transcriptome Analysis

    • Whole Genome

    • Chip Seq Analysis

    • De novo Assembly

    • Methyl Seq Analysis

  • Chemoinformatics

    • Sequence Analysis Platforms

    • Molecular Modeling

    • Docking

    • Clinical trial data management

    • Others

  • Microarray data analysis

  • Biological data curation

  • Scientific software testing

  • Other services

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Genomics

  • Transcriptomics

  • Proteomics

  • Metabolomics

  • Drug Discovery

  • Others

• Sector Outlook (Revenue, USD Million, 2021 - 2033)

  • Medical

  • Animal

  • Agricultural

  • Academics

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Delivered Customizations

This report has been delivered with the following In-depth customizations